Mike Adelman
Oncology
Aptevo Therapeutics
United States of America
Biography
Mr. Adelman leads all commercial functions at Aptevo Therapeutics as VP, Commercial Operations, a position that he has held since 2012 at Cangene Corporation, which was acquired by Emergent in 2014. Mr. Adelman brings over 20 years of industry-specific commercial leadership experience in areas including sales, marketing, contracting, pricing, commercial analytics, and alliance management. Prior to joining Cangene, Mr. Adelman was VP of Marketing and Sales at Adolor Corporation and Sr. Director, Marketing Strategy at AstraZeneca.
Research Interest
Oncology